Beta-blockers will continue to fall out of favor for hypertension
Beta-blockers will continue to fall out of favor for hypertension...especially atenolol.
Beta-blockers seem to prevent fewer CV events in patients with hypertension than other BP meds...despite similar BP lowering.
Atenolol has a particularly bad reputation...because most hypertension trials evaluating cardiovascular risk used atenolol.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote